| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia. | Cell Death Dis | 2017 | 0.75 |
| 2 | Defining the Disease-Specific Antigenic Repertoire. | Front Microbiol | 2020 | 0.75 |
| 3 | Targeted Delivery of Neutralizing Anti-C5 Antibody to Renal Endothelium Prevents Complement-Dependent Tissue Damage. | Front Immunol | 2017 | 0.75 |
| 4 | Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects. | Amino Acids | 2016 | 0.75 |